| GENERIC NAME | This data is not available for free |
| PARTNER | This data is not available for free |
| INDICATION'S | Hepatitis C (In Combi. with IFN Alpha 2a) |
| STATUS |
Co. targets to submit a marketing authorization application for Ravanex, either first to a national agency and then through a mutual recognition procedure for European-wide approval or to the EMEA through the decentralized procedure, in the second half of 2006. |
| UPDATE | 12.11.06 |
| COMPANY | This data is not available for free |
| PATENT ASSIGNEE | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |